Companies / Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals Inc

Nasdaq: SUPNCIK 1356576ROCKVILLE, MD

Financials · FY2025

Revenue$718.95M
Net income$-38.55M
Total debt$0
Cash$179.95M
Diluted EPS$-0.68
Shares outstanding58.1M

Ownership

58.1M shares outstanding · as of Jul 28, 2026
4.3%Insiders
Ownership
Insiders4.29%2,495,155
10%+ / strategic15.36%8,928,193
Institutions96.11%55,863,329
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 11

View all →
Insider% of sharesShares
Khattar Jack A.CEOPresident, CEO · Director
3.78%2,199,244
Newhall Charles W IIIDirector
0.21%124,119
Hudson Frederick M.Director
0.10%60,413
Gemayel GeorgesDirector
0.05%27,277
Barlow CarroleeDirector
0.05%27,045
Mottola FrankSVP, Chief Tech. Ops. Officer
0.03%18,440
Bhatt Padmanabh P.Sr. VP of IP, CSO
0.03%17,044
Rubin JonathanSVP, Chief Medical Officer
0.02%13,341
Dec Timothy CSenior Vice-President & CFO
0.01%8,232
Horich William ToddSVP, Commercial Operations
0.00%0

Institutional holders 341

View all →
HolderValue% of shares
BlackRock, Inc.$434.87M16.09%
Vanguard Group Inc$300.61M10.41%
Millennium Management LLC$171.40M5.70%
Armistice Capital, LLC$137.37M4.76%
Dimensional Fund Advisors LP$134.80M4.67%
Nomura Asset Management International Inc.$114.69M3.97%
State Street Corporation$114.41M4.23%
Point72 Asset Management, L.P.$112.56M3.90%
Renaissance Technologies LLC$88.14M2.93%
Geode Capital Management, LLC$83.93M2.79%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 16, 2026Bhatt Padmanabh P.
Executive
SellCommon Stock$1.71M-34K
-50.88%
32,930
0.06% of shares
medium
Mar 17, 2026Bhatt Padmanabh P.
Executive
SellCommon Stock$1.38M-28K
-41.33%
39,334
0.07% of shares
medium
Mar 13, 2026Khattar Jack A.
CEO
SellCommon Stock$1.21M-24K
-2.43%
968,962
1.67% of shares
medium
Mar 17, 2026Bhatt Padmanabh P.
Executive
SellCommon Stock$1.13M-22K
-56.67%
17,044
0.03% of shares
medium
Mar 6, 2026Khattar Jack A.
CEO
OtherCommon Stock$907.1K-17K
-1.33%
1,228,644
2.11% of shares
low
Mar 17, 2026Bhatt Padmanabh P.
Executive
ExerciseCommon Stock$896.4K+23K
+133.48%
39,794
0.07% of shares
low
Mar 16, 2026Bhatt Padmanabh P.
Executive
ExerciseCommon Stock$836.1K+23K
+133.48%
39,794
0.07% of shares
low
Mar 16, 2026Bhatt Padmanabh P.
Executive
SellCommon Stock$802.1K-16K
-48.24%
17,044
0.03% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Millennium Management LLCPassive13G/A———
Millennium Management LLCPassive13G———
Dimensional Fund Advisors LPPassive13G/A———
Armistice Capital, LLCPassive13G/A—2,764,000—
Vanguard Portfolio ManagementPassive13G—3,263,309—
Vanguard Capital ManagementPassive13G—2,900,884—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
SUPN——868459108—